Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for spasticity in children with cerebral palsy or traumatic CNS injury
NCT01898520Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Dec 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of cannabidiol in spasticity, sponsored by Jazz Pharmaceuticals plc. Started Dec 2013; status: completed.
02
Drugs
cannabidiol
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT01898520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898520.